Adempas- 1MG tab-90CT. Bottle JAN FY26- $12,153.05
Ended Awarded Last action
- Contract number
- 15B50526F00000028
- Awardee
-
Bayer Healthcare Pharmaceuticals Inc. UEI V1EVGCK7XES8 Part of Bayer Aktiengesellschaft
- Awarding agency
-
Federal Medical Center Carswell
Correctional Facilities, Department of Justice
- Obligated
- $12,153
Award facts
- Contract value 100% obligated
- $12,153.05 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- Q517 Pharmacy Services
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Whippany, Hanover, NJ 07981, USA
Award details come from SAM.gov/FPDS.
About this award
Bayer Healthcare Pharmaceuticals Inc., a subsidiary of Germany-based Bayer AG, was awarded a delivery order valued at $12,153.05 for 90 count bottles of Adempas 1mg tablets for January fiscal year 2026. The award was issued by the Federal Medical Center Carswell, a civilian facility within the federal healthcare system, with performance completed in Whippany, Hanover, New Jersey. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract maintained with the Department of Veterans Affairs, which carries an $840 million potential value and enables multiple federal agencies to rapidly procure pharmaceutical products through task orders. The contract utilized firm fixed-price pricing with no small business set-aside designation, reflecting Bayer's status as a large, foreign-owned pharmaceutical enterprise.
Adempas (riociguat) is a specialized medication used to treat pulmonary arterial hypertension, representing critical pharmaceutical support for federal healthcare beneficiaries. This delivery order represents routine procurement activity under Bayer's broader federal pharmaceutical contracting portfolio, which also includes the company's $6.8 million Blanket Purchase Agreement with the VA National Acquisition Center specifically designated for Xofigo and Adempas. The award demonstrates the ongoing reliance of federal medical facilities on Bayer's specialized pharmaceutical products to support treatment programs for veterans and other federal healthcare populations.
Quick answers
Who was awarded contract 15B50526F00000028?
15B50526F00000028 was awarded to Bayer Healthcare Pharmaceuticals Inc. by Federal Medical Center Carswell (Correctional Facilities) on January 31, 2026.
How much is contract 15B50526F00000028 worth?
The government has obligated $12,153 on 15B50526F00000028.
Is contract 15B50526F00000028 an order under another contract?
Yes. 15B50526F00000028 is a delivery order under 36F79720D0237, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 15B50526F00000028 competed?
The extent of competition for 15B50526F00000028 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award